Defining the Immunomodulatory Role of GPNMB in Triple Negative Breast Cancer
Defining the Immunomodulatory Role of GPNMB in Triple Negative Breast Cancer
批准号:
468016
负责人:
Siegel Peter M
金额:
$72.45万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-09-01 至 2027-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
BACKGROUND: The body can mount an anti-tumor immune response to eliminate cancer cells. However, cancer cells that are able to evade the immune system can continue to grow and progress to metastatic disease (gain the ability to spread form the primary sit
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying tumor-derived and microenvironmental factors that drive invasive growth of brain metastases
-
批准号:433618
-
项目类别:Operating Grants
-
资助金额:$75.24万
-
财政年份:2020
-
负责人:Siegel Peter M
-
依托单位:
Deciphering the multi-faceted roles of Afadin in breast cancer metastasis
-
批准号:433637
-
项目类别:Operating Grants
-
资助金额:$69.66万
-
财政年份:2020
-
负责人:Siegel Peter M
-
依托单位:
Optimizing Combination Strategies for GPNMB-expressing Triple Negative Breast Cancers
-
批准号:354630
-
项目类别:Operating Grants
-
资助金额:$62.7万
-
财政年份:2016
-
负责人:Siegel Peter M
-
依托单位:
Metabolic Adaptations During Breast Cancer Metastasis
-
批准号:343339
-
项目类别:Operating Grants
-
资助金额:$61.26万
-
财政年份:2016
-
负责人:Siegel Peter M
-
依托单位:
Claudin-2 as a Prognostic and Therapeutic Target in Breast Cancer Liver Metastasis
-
批准号:304512
-
项目类别:Operating Grants
-
资助金额:$55.48万
-
财政年份:2014
-
负责人:Siegel Peter M
-
依托单位:
GPNMB as an emerging therapeutic target in metastatic breast cancer
-
批准号:237743
-
项目类别:Operating Grants
-
资助金额:$53.17万
-
财政年份:2011
-
负责人:Siegel Peter M
-
依托单位:
海外基金